WASHINGTON—The U.S. House of Representatives Wednesday passed the Food and Drug Administration Safety and Innovation Act (S. 3187), a bill to support the FDA’s drug and device reviews.
"We commend the House for passing the bipartisan Food and Drug Administration Safety and Innovation Act," said Allan Coukell, director of medical programs at the Pew Health Group. "This legislation will help deliver safe, effective and innovative medical products to patients. We also commend the Energy and Commerce Committee for its leadership throughout this process. We look forward to the bill’s passage through the U.S. Senate."
On Thursday, May 23, the House Energy & Commerce Subcommittee on Health held a hearing, entitled "Examining Drug Compounding." Gabrielle Cosel, a drug safety expert, testified on the need to clarify oversight of compounding pharmacies on the state and federal level.
More info
Public health and consumer advocacy groups are attacking Senate legislation designed to tighten oversight of specialized pharmacies such as the one at the center of this past fall’s deadly meningitis outbreak, saying it does not adequately address health risks.
More infoCopyright(c) 1996-2012 The Pew Charitable Trusts. All Rights Reserved.
[+] Feedback PHG.PRODUCTION.1.20130430.1322 (PEWSUWVMWAPP01)
